| Reported | Recall | Class | Product | Firm |
|---|
| 2023-05-03 | D-0554-2023 | Class II | Tadalafil Tablets | Northwind Pharmaceuticals LLC |
| 2023-05-03 | D-0555-2023 | Class III | Oxytocin 30 units added to 0 | SCA Pharmaceuticals |
| 2023-05-03 | D-0569-2023 | Class II | Fyremadel | Sun Pharmaceutical Industries Ltd. |
| 2023-04-26 | D-0536-2023 | Class II | Verapamil Hydrochloride Extended-Release Tablets | Amerisource Health Services LLC |
| 2023-04-26 | D-0537-2023 | Class II | Fast Acting Earwax Removal System | Pharma Nobis LLC |
| 2023-04-26 | D-0538-2023 | Class II | C-Semaglutide 5mg/mL injection | Pharmacy Plus, Inc. dba Vital Care Compounder |
| 2023-04-26 | D-0539-2023 | Class II | Aripiprazole Tablets | Ascend Laboratories, LLC |
| 2023-04-19 | D-0529-2023 | Class III | Norepinephrine Bitartrate Injection | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-04-19 | D-0530-2023 | Class II | Pantoprazole Sodium Delayed Release Tablets USP 40mg | Hetero USA Inc |
| 2023-04-19 | D-0531-2023 | Class III | Bevacizumab 2 | Pine Pharmaceuticals, LLC |
| 2023-04-19 | D-0532-2023 | Class III | MEKTOVI | Pfizer Inc. |
| 2023-04-19 | D-0535-2023 | Class III | Epinephrine Professional EMS | Focus Health Group Inc |
| 2023-04-12 | D-0489-2023 | Class II | Testosterone Cypionate Injection | Azurity Pharmaceuticals, Inc. |
| 2023-04-12 | D-0490-2023 | Class II | Aripiprazole 5mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0491-2023 | Class II | Atorvastatin 10 mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0492-2023 | Class II | Doxazosin 2 mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0493-2023 | Class II | Glimepiride 2 mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0494-2023 | Class II | Ropinirole 0 | RemedyRepack Inc. |
| 2023-04-12 | D-0495-2023 | Class II | Rosuvastatin 5mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0496-2023 | Class II | Simvastatin 10 mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0497-2023 | Class II | Tadalafil 5 mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0498-2023 | Class II | Atorvastatin 20 mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0499-2023 | Class II | Ropinirole 2mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0500-2023 | Class II | Rosuvastatin 5mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0501-2023 | Class II | Rosuvastatin 10mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0502-2023 | Class II | Rosuvastatin 40mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0503-2023 | Class II | Simvastatin 40 mg tablets | RemedyRepack Inc. |
| 2023-04-12 | D-0504-2023 | Class II | Alprazolam Tab | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0505-2023 | Class II | Alprazolam Tab | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0506-2023 | Class II | Alprazolam Tab | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0507-2023 | Class II | Alprazolam C-IV | Direct Rx |
| 2023-04-12 | D-0508-2023 | Class II | Alprazolam C-IV | Direct Rx |
| 2023-04-12 | D-0509-2023 | Class II | Alprazolam C-IV | Direct Rx |
| 2023-04-12 | D-0510-2023 | Class III | Montelukast Sodium Oral Granules USP | Teva Pharmaceuticals USA Inc |
| 2023-04-12 | D-0511-2023 | Class II | Atorvastatin Calcium Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0512-2023 | Class II | Atorvastatin Calcium Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0513-2023 | Class II | Clopidogrel Tablets USP | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0514-2023 | Class II | Doxazosin Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0515-2023 | Class II | Doxazosin Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0516-2023 | Class II | Finasteride Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0517-2023 | Class II | Glimepiride Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0518-2023 | Class II | Montelukast Sodium Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0519-2023 | Class II | Rosuvastatin Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0520-2023 | Class II | Rosuvastatin Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0521-2023 | Class II | Pravastatin Sodium Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0522-2023 | Class II | Simvastatin Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0523-2023 | Class II | Simvastatin Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0524-2023 | Class II | Simvastatin Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0525-2023 | Class II | Simvastatin Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0526-2023 | Class II | Tadalafil Tablets | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0527-2023 | Class II | Glimepiride Tablets USP | Preferred Pharmaceuticals, Inc. |
| 2023-04-12 | D-0528-2023 | Class III | Dodex Injectable Cyanocobalamin Injection | Accord Healthcare, Inc. |
| 2023-04-05 | D-0475-2023 | Class II | Calcitonin Salmon Nasal Spray | Endo Pharmaceuticals, Inc. |
| 2023-04-05 | D-0476-2023 | Class II | Montelukast Sodium Tablets | Direct Rx |
| 2023-04-05 | D-0477-2023 | Class II | Finasteride | Direct Rx |
| 2023-04-05 | D-0478-2023 | Class II | Ropinirole | Direct Rx |
| 2023-04-05 | D-0479-2023 | Class II | Ropinirole | Direct Rx |
| 2023-04-05 | D-0480-2023 | Class II | Glimepiride | Direct Rx |
| 2023-04-05 | D-0481-2023 | Class II | Glimepiride | Direct Rx |
| 2023-04-05 | D-0482-2023 | Class II | Glimepiride | Direct Rx |
| 2023-04-05 | D-0483-2023 | Class II | Simvastatin | Direct Rx |
| 2023-04-05 | D-0484-2023 | Class II | Simvastatin | Direct Rx |
| 2023-04-05 | D-0485-2023 | Class II | Simvastatin | Direct Rx |
| 2023-04-05 | D-0486-2023 | Class II | Simvastatin | Direct Rx |
| 2023-04-05 | D-0487-2023 | Class II | Fentanyl 500mcg | Apollo Care |
| 2023-04-05 | D-0533-2023 | Class II | Dabigatran Etexilate Capsules | Ascend Laboratories, LLC |
| 2023-04-05 | D-0534-2023 | Class II | Dabigatran Etexilate 150mg Capsules | Ascend Laboratories, LLC |
| 2023-03-29 | D-0468-2023 | Class II | JARDIANCE | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2023-03-29 | D-0470-2023 | Class II | Daytrana | Noven Pharmaceuticals Inc |
| 2023-03-29 | D-0471-2023 | Class II | Daytrana | Noven Pharmaceuticals Inc |
| 2023-03-29 | D-0472-2023 | Class II | Daytrana | Noven Pharmaceuticals Inc |
| 2023-03-29 | D-0473-2023 | Class II | Daytrana | Noven Pharmaceuticals Inc |
| 2023-03-29 | D-0474-2023 | Class III | Dofetilide Capsules | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-03-29 | D-0488-2023 | Class I | Delsam Pharma's Artificial Eye Ointment | Global Pharma Healthcare Private Limited |
| 2023-03-22 | D-0458-2023 | Class II | Alprazolam Tablets | Breckenridge Pharmaceutical, Inc |
| 2023-03-22 | D-0459-2023 | Class II | Alprazolam Tablets | Breckenridge Pharmaceutical, Inc |
| 2023-03-22 | D-0460-2023 | Class II | Alprazolam Tablets | Breckenridge Pharmaceutical, Inc |
| 2023-03-22 | D-0461-2023 | Class II | Alprazolam Tablets | Breckenridge Pharmaceutical, Inc |
| 2023-03-22 | D-0462-2023 | Class II | Clobazam Tablets | Breckenridge Pharmaceutical, Inc |
| 2023-03-22 | D-0463-2023 | Class II | Clobazam Tablets | Breckenridge Pharmaceutical, Inc |
| 2023-03-22 | D-0464-2023 | Class III | Evamist | Padagis US LLC |
| 2023-03-22 | D-0465-2023 | Class III | Buprenorphine Transdermal System | AVEVA Drug Delivery Systems, Inc. |
| 2023-03-22 | D-0466-2023 | Class III | Buprenorphine Transdermal System | AVEVA Drug Delivery Systems, Inc. |
| 2023-03-22 | D-0467-2023 | Class III | Colchicine Tablets | Zydus Pharmaceuticals (USA) Inc |
| 2023-03-22 | D-0469-2023 | Class II | Clear Eyes | Teva Pharmaceuticals USA Inc |
| 2023-03-15 | D-0433-2023 | Class II | Brimonidine Tartrate Ophthalmic Solution 0 | Apotex Corp. |
| 2023-03-15 | D-0434-2023 | Class II | Heparin Sodium | B. Braun Medical Inc |
| 2023-03-15 | D-0435-2023 | Class II | Heparin Sodium Injection | Sagent Pharmaceuticals Inc |
| 2023-03-15 | D-0436-2023 | Class II | Verapamil Hydrochloride Extended-Release Tablets | Amerisource Health Services LLC |
| 2023-03-15 | D-0437-2023 | Class II | NaturalCare bioAllers | Nutraceutical Corporation |
| 2023-03-15 | D-0438-2023 | Class II | NatraBio | Nutraceutical Corporation |
| 2023-03-15 | D-0439-2023 | Class II | NaturalCare bioAllers | Nutraceutical Corporation |
| 2023-03-15 | D-0440-2023 | Class II | NaturalCare | Nutraceutical Corporation |
| 2023-03-15 | D-0441-2023 | Class II | Metformin hydrochloride Extended-Release Tablets | Teva Pharmaceuticals USA Inc |
| 2023-03-15 | D-0442-2023 | Class II | Phenylephrine HCl 0 | Denver Solutions, LLC DBA Leiters Health |
| 2023-03-15 | D-0443-2023 | Class II | Phenylephrine HCl 1mg per 10mL | Denver Solutions, LLC DBA Leiters Health |
| 2023-03-15 | D-0444-2023 | Class II | Phenylephrine HCl 40 mg | Denver Solutions, LLC DBA Leiters Health |
| 2023-03-15 | D-0445-2023 | Class II | Phenylephrine HCl 20 mg | Denver Solutions, LLC DBA Leiters Health |
| 2023-03-15 | D-0446-2023 | Class II | Alcolado Relampago | Ecometics, Inc. |
| 2023-03-15 | D-0447-2023 | Class II | Vencedor medicated balm | Ecometics, Inc. |
| 2023-03-15 | D-0448-2023 | Class II | Unguentine Original Ointment for Burns | Ecometics, Inc. |
| 2023-03-15 | D-0449-2023 | Class II | Soltice Quick-RUB | Ecometics, Inc. |
| 2023-03-15 | D-0450-2023 | Class II | Nose Better Gel | Ecometics, Inc. |
| 2023-03-15 | D-0451-2023 | Class II | Activator Concentrate | Ecometics, Inc. |
| 2023-03-15 | D-0452-2023 | Class II | Unguentine Original Maximum Strength Pain Relieving/Antiseptic… | Ecometics, Inc. |
| 2023-03-15 | D-0454-2023 | Class III | DIBUCAINE 1% HEMORRHOIDAL OINTMENT | Akron Pharma, Inc. |
| 2023-03-15 | D-0455-2023 | Class I | Snowy Range Blue Alcohol Antiseptic 80% Topical Solution Hand… | Nanomaterials Discovery Corporation |
| 2023-03-15 | D-0456-2023 | Class I | Purely Soothing 15% MSM Drops | Pharmedica USA, LLC |
| 2023-03-15 | D-0457-2023 | Class II | Purely Soothing MSM Nasal Spray | Pharmedica USA, LLC |
| 2023-03-08 | D-0349-2023 | Class III | Avicel PH- 101 NF | DuPont Nutrition USA, Inc |
| 2023-03-08 | D-0350-2023 | Class III | Avicel PH- 102 NF | DuPont Nutrition USA, Inc |
| 2023-03-08 | D-0351-2023 | Class III | Avicel PH-200 NF | DuPont Nutrition USA, Inc |
| 2023-03-08 | D-0352-2023 | Class III | BD-102 NF | DuPont Nutrition USA, Inc |
| 2023-03-08 | D-0353-2023 | Class II | Levothyroxine Sodium Tablets | Alvogen, Inc |
| 2023-03-08 | D-0354-2023 | Class III | Gabapentin Tablets | Sciegen Pharmaceuticals Inc |
| 2023-03-08 | D-0355-2023 | Class II | Diltiazem HCl in 0 | Nephron Sterile Compounding Center LLC |
| 2023-03-08 | D-0356-2023 | Class II | Norepinephrine Bitartrate in 0 | Nephron Sterile Compounding Center LLC |
| 2023-03-08 | D-0357-2023 | Class II | Norepinephrine Bitartrate in 0 | Nephron Sterile Compounding Center LLC |
| 2023-03-08 | D-0358-2023 | Class II | Norepinephrine Bitartrate in 0 | Nephron Sterile Compounding Center LLC |
| 2023-03-08 | D-0359-2023 | Class II | Phenylephrine HCl Injection | Nephron Sterile Compounding Center LLC |
| 2023-03-08 | D-0360-2023 | Class II | Phenylephrine HCl Injection | Nephron Sterile Compounding Center LLC |
| 2023-03-08 | D-0361-2023 | Class II | Phenylephrine HCl Injection | Nephron Sterile Compounding Center LLC |
| 2023-03-08 | D-0362-2023 | Class II | Phenylephrine HCl in 0 | Nephron Sterile Compounding Center LLC |
| 2023-03-08 | D-0363-2023 | Class III | Fentanyl 1 | SCA Pharmaceuticals |
| 2023-03-08 | D-0364-2023 | Class II | Sterile Water for Injection | Nephron Sc Inc |
| 2023-03-08 | D-0365-2023 | Class II | Aripiprazole Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0366-2023 | Class II | Aripiprazole Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0367-2023 | Class II | Aripiprazole Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0368-2023 | Class II | Aripiprazole Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0369-2023 | Class II | Aripiprazole Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0370-2023 | Class II | Aripiprazole Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0371-2023 | Class II | Atorvastatin Calcium Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0372-2023 | Class II | Atorvastatin Calcium Tablets USP 20 mg* Rx Only | Accord Healthcare, Inc. |
| 2023-03-08 | D-0373-2023 | Class II | Atorvastatin Calcium Tablets USP 40 mg* Rx Only | Accord Healthcare, Inc. |
| 2023-03-08 | D-0374-2023 | Class II | Atorvastatin Calcium Tablets USP 80 mg* Rx Only | Accord Healthcare, Inc. |
| 2023-03-08 | D-0375-2023 | Class II | BusPIRone Hydrochloride Tablets USP 7 | Accord Healthcare, Inc. |
| 2023-03-08 | D-0376-2023 | Class II | BusPIRone Hydrochloride Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0377-2023 | Class II | BusPIRone Hydrochloride Tablets USP 15 mg | Accord Healthcare, Inc. |
| 2023-03-08 | D-0378-2023 | Class II | BusPIRone Hydrochloride Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0379-2023 | Class II | BusPIRone Hydrochloride Tablets USP 30 mg | Accord Healthcare, Inc. |
| 2023-03-08 | D-0380-2023 | Class II | Clopidogrel Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0381-2023 | Class II | Daptomycin for Injection 350 mg/vial | Accord Healthcare, Inc. |
| 2023-03-08 | D-0382-2023 | Class II | Daptomycin for Injection 500 mg per vial | Accord Healthcare, Inc. |
| 2023-03-08 | D-0383-2023 | Class II | Dofetilide Capsules | Accord Healthcare, Inc. |
| 2023-03-08 | D-0384-2023 | Class II | Dofetilide Capsules 250 mcg | Accord Healthcare, Inc. |
| 2023-03-08 | D-0385-2023 | Class II | Dofetilide Capsules 500 mcg | Accord Healthcare, Inc. |
| 2023-03-08 | D-0386-2023 | Class II | Doxazosin Tablets USP 1 mg | Accord Healthcare, Inc. |
| 2023-03-08 | D-0387-2023 | Class II | Doxazosin Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0388-2023 | Class II | Doxazosin Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0389-2023 | Class II | Doxazosin Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0390-2023 | Class II | Finasteride Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0391-2023 | Class II | Finasteride Tablets USP 1 mg | Accord Healthcare, Inc. |
| 2023-03-08 | D-0392-2023 | Class II | Finasteride Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0393-2023 | Class II | Glimepiride Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0394-2023 | Class II | Glimepiride Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0395-2023 | Class II | Glimepiride Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0396-2023 | Class II | Glycopyrrolate Injection | Accord Healthcare, Inc. |
| 2023-03-08 | D-0397-2023 | Class II | Glycopyrrolate Injection | Accord Healthcare, Inc. |
| 2023-03-08 | D-0398-2023 | Class II | Glycopyrrolate Injection | Accord Healthcare, Inc. |
| 2023-03-08 | D-0399-2023 | Class II | Glycopyrrolate Injection | Accord Healthcare, Inc. |
| 2023-03-08 | D-0400-2023 | Class II | Montelukast Sodium Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0401-2023 | Class II | Phenylephrine Hydrochloride Injection | Accord Healthcare, Inc. |
| 2023-03-08 | D-0402-2023 | Class II | Phenylephrine Hydrochloride Injection | Accord Healthcare, Inc. |
| 2023-03-08 | D-0403-2023 | Class II | Phenylephrine Hydrochloride Injection | Accord Healthcare, Inc. |
| 2023-03-08 | D-0404-2023 | Class II | Rosuvastatin Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0405-2023 | Class II | Rosuvastatin Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0406-2023 | Class II | Rosuvastatin Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0407-2023 | Class II | Rosuvastatin Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0408-2023 | Class II | Simvastatin Tablets USP 5 mg Rx Only | Accord Healthcare, Inc. |
| 2023-03-08 | D-0409-2023 | Class II | Simvastatin Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0410-2023 | Class II | Simvastatin Tablets USP 20 mg Rx Only | Accord Healthcare, Inc. |
| 2023-03-08 | D-0411-2023 | Class II | Simvastatin Tablets USP 40 mg Rx Only | Accord Healthcare, Inc. |
| 2023-03-08 | D-0412-2023 | Class II | Simvastatin Tablets USP 80 mg Rx Only | Accord Healthcare, Inc. |
| 2023-03-08 | D-0413-2023 | Class II | Succinylcholine Chloride Injection | Accord Healthcare, Inc. |
| 2023-03-08 | D-0414-2023 | Class II | Tadalafil Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0415-2023 | Class II | Tadalafil Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0416-2023 | Class II | Tadalafil Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0417-2023 | Class II | Tadalafil Tablets | Accord Healthcare, Inc. |
| 2023-03-08 | D-0418-2023 | Class II | Vigabatrin for Oral Solution | Accord Healthcare, Inc. |
| 2023-03-08 | D-0419-2023 | Class II | Pirfenidone Tablets 267 mg 90-count bottle x3/Carton | Accord Healthcare, Inc. |
| 2023-03-08 | D-0420-2023 | Class II | Pirfenidone Tablets 801 mg | Accord Healthcare, Inc. |
| 2023-03-08 | D-0421-2023 | Class II | Pravastatin Sodium Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0422-2023 | Class II | Pravastatin Sodium Tablets USP 20 mg | Accord Healthcare, Inc. |
| 2023-03-08 | D-0423-2023 | Class II | Pravastatin Sodium Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0424-2023 | Class II | Pravastatin Sodium Tablets USP | Accord Healthcare, Inc. |
| 2023-03-08 | D-0425-2023 | Class II | rOPINIRole Tablets USP 0 | Accord Healthcare, Inc. |
| 2023-03-08 | D-0426-2023 | Class II | rOPINIRole Tablets USP 0 | Accord Healthcare, Inc. |
| 2023-03-08 | D-0427-2023 | Class II | rOPINIRole Tablets USP 1 mg* | Accord Healthcare, Inc. |
| 2023-03-08 | D-0428-2023 | Class II | rOPINIRole Tablets USP 2 mg* | Accord Healthcare, Inc. |
| 2023-03-08 | D-0429-2023 | Class II | rOPINIRole Tablets USP 3 mg* | Accord Healthcare, Inc. |
| 2023-03-08 | D-0430-2023 | Class II | rOPINIRole Tablets USP 4 mg* 100-count bottle | Accord Healthcare, Inc. |
| 2023-03-08 | D-0431-2023 | Class II | rOPINIRole Tablets USP 5 mg* 100-count bottle | Accord Healthcare, Inc. |
| 2023-03-08 | D-0432-2023 | Class II | Carbidopa and Levodopa Tablets | The Harvard Drug Group |
| 2023-03-08 | D-0453-2023 | Class I | PrimeZEN Black 6000 capsule | Volt Candy Wholesale Club |
| 2023-03-01 | D-0329-2023 | Class III | Dermoplast FIRST AID ANTIBACTERIAL SPRAY | Advantice Health, Llc |
| 2023-03-01 | D-0330-2023 | Class II | Tacrolimus Capsules | Dr. Reddy's Laboratories, Inc. |
| 2023-03-01 | D-0331-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0332-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0333-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0334-2023 | Class II | TIROSINT | IBSA PHARMA INC |